Repare Therapeutics Inc. Common Stock, Value, Issued
Repare Therapeutics Inc. had Common Stock, Value, Issued of $490.49 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2025-11-14
- 2025-09-30: Common Stock, Value, Issued $490.49M.
- 2025-06-30: Common Stock, Value, Issued $490.43M.
- 2025-03-31: Common Stock, Value, Issued $489.84M.
- 2024-12-31: Common Stock, Value, Issued $486.67M.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2025-09-30 | $490.49M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $490.43M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $489.84M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $486.67M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $486.67M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $486.38M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $486.38M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $483.35M 10-K · filed 2025-03-03 |
| 2023-09-30 | $483.18M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $482.74M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $482.68M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $482.03M 10-K · filed 2024-02-28 |
| 2022-09-30 | $481.78M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $481.38M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $481.05M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $480.70M 10-K · filed 2023-02-28 |
| 2021-09-30 | $385.99M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $385.45M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $384.61M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $384.31M 10-K · filed 2022-03-01 |
| 2020-09-30 | $383.85M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $383.82M 10-Q · filed 2020-08-13 |
| 2019-12-31 | $1.00K 10-K · filed 2021-03-04 |